Clinical Trial Update: PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the completion of the PROMPT study evaluating palifermin for reducing oral mucositis in peripheral blood stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Non-Hodgkin's Lymphoma, Multiple Myeloma | Phase 4 | Status: COMPLETED